The Patent Finder

Immunotope, Inc.

Also on record
Records under this name other than the patents Immunotope, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 4 of 4 · Back to Immunotope, Inc.

PatentTitleStatus Expires Confidence
US 9,907,842Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer
Lapsed on the fee record
Ended Mar 6, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 6, 2026From the USPTO record
US 9,624,284Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer
Lapsed on the fee record
Ended Apr 18, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 18, 2025From the USPTO record
US 7,919,467Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment, and Diagnosis of Cancer
Lapsed on the fee record
Ended Apr 5, 2019 · High confidence
Lapsed on the fee recordEnded Apr 5, 2019High confidence
US 7,083,789Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment, and Diagnosis of Cancer
Formerly held
Lapsed on the fee record
Ended Aug 1, 2018 · High confidence
Lapsed on the fee recordEnded Aug 1, 2018High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited